The EMPERIE consortium as a whole.
EMPERIE incorporates all relevant research fields, including molecular virology, pathology, immunology, mathematical modeling, epidemiology,microbial genomics, public health research and emergency preparedness. The result is a multidisciplinary, balanced consortium consisting of twelve partners:
|Institute||Principal Investigators involved|
|Erasmus MC||Prof. dr. Ab Osterhaus, Prof. dr. Ron Fouchier, Prof. dr. Thijs Kuiken|
|UniversitaetsKlinikum Bonn||Prof. dr. Christian Drosten, Dr. Marcus Mueller, Dr. Felix Drexler|
|Institut Pasteur||Prof.dr. Sylvie van der Werf, dr. Noel Tordo|
|University of Hong Kong||Prof.dr. Malik Peiris, Dr. Leo Poon|
|ViroClinics Biosciences||Dr. Bob van Gemen|
|Academic Medical Center||Prof. dr. Menno de Jong, Dr. Lia van der Hoek|
|Imperial College||Prof. dr. Neil Ferguson|
|University of Cambridge||Prof. dr. Derek Smith|
|Genome Research Ltd||Dr. Paul Kellam|
|University of Oxford||Prof.dr. Jeremy Farrar|
|Consejo Superior de Investigaciones Cientificas||Prof.dr. Luis Enjuanes|
|Friedrich Loeffler Institut||Dr. Martin Beer|
EMPERIE will build on the capabilities of the participants, each of which have led the discovery and characterisation of additional new or unidentified infectious agents, identified their routes of transmission, analyzed genetic and phenotypic variation, designed control strategies, and gathered deep epidemiological understanding. Pathogens for which extensive experience at the different levels is available within the consortium include numerous recently emerging pathogens, such as orthomyxoviruses (human epidemic influenza viruses, avian viruses, zoonotic viruses H5N1, H7N7, H9N2), paramyxoviruses (Hendra/Nipah, human metapneumovirus) coronaviruses (SARS, NL63, HKU), flaviviruses (Dengue, West-Nile virus), Alphaviruses (Chikungunya), Bunyavirus (Hantavirus and CCHF virus), and filoviruses (Ebolavirus). Thus, all of the EMPERIE partners have an established track record in the field, and collectively EMPERIE has all the (proven) expertise, know how and resources necessary for the work outlined in this proposal on human, animal and zoonotic infectious diseases. In addition, all the EMPERIE partners have a proven strong track record on intensive and loyal collaboration during international infectious disease crisis situations, which will form a solid basis for similar collaborative actions in the future.
We envisage a multidisciplinary team that combines the world-class expertise of individual research groups that share their specific expertises, technologies, reagents, information to strengthen the surveillance, pathogen identification, modelling and prediction of newly emerging infectious diseases within the team on the whole and beyond, by involving relevant academic, medical, and commercial partners.